1. Possible mechanism for the inhibition of gastric (H1,K1)-adenosine triphosphatase by the proton pump inhibitor AG-1749;Nagaya;J. Pharmacol. Exp. Ther.,1989
2. Lansoprazole—a review of its pharmacodynamic and pharmacokinetics properties and its therapeutic efficacy in acid-related disorders;Baradell;Drugs,1992
3. Lansoprazole—a reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders;Spencer;Drugs,1994
4. Pharmacokinetics and absolute bioavailability of lansoprazole;Gerloff;Eur. J. Clin. Pharmacol.,1996
5. The effect of food and antacids on lansoprazole absorption and distribution;Landes;Eur. J. Drug Metab. Pharmacokinet.,1991